Imugene is partnering with another research phase company. It looks like a good match - combining OnCARlytics with a next generation CAR-T. Just don't expect immediate $$ to flow from this - it's a longer term project with no revenue in the short term.
It continues Imugene's strategic path of broadening their IP and product base - with a partner who will probably do a lot of the work - further derisking Imugene. This is just one direction for OnCARlytics - and it could be very successful. I expect Imugene will end up with several partners for further development of OnCARlytics.
Another good move on the Biotech chessboard. Plenty more to come, and the money will follow in due course.
Cheers
Dave![]()
- Forums
- ASX - By Stock
- IMU
- Ann: Research partnership with Celularity for solid tumors
Ann: Research partnership with Celularity for solid tumors, page-14
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
7.6¢ |
Change
0.014(22.6%) |
Mkt cap ! $587.9M |
Open | High | Low | Value | Volume |
7.3¢ | 8.1¢ | 7.3¢ | $9.591M | 123.6M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2168241 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 1057425 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 2254408 | 0.076 |
14 | 2585386 | 0.075 |
13 | 6542845 | 0.074 |
9 | 4488680 | 0.073 |
10 | 770483 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 1004802 | 13 |
0.078 | 569836 | 9 |
0.079 | 885577 | 6 |
0.080 | 1237795 | 13 |
0.081 | 1621740 | 10 |
Last trade - 11.59am 02/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online